BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 174412)

  • 1. Murine cytomegalovirus (MCMV).
    Lussier G
    Adv Vet Sci Comp Med; 1975; 19():223-47. PubMed ID: 174412
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo model for the acute, latent and reactivated phases of cytomegalovirus infection.
    Gönczöl E; Danczig E; Boldogh I; Tóth T; Váczi L
    Acta Microbiol Hung; 1985; 32(1):39-47. PubMed ID: 2994350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppression reactivates and disseminates latent murine cytomegalovirus.
    Jordan MC; Shanley JD; Stevens JG
    J Gen Virol; 1977 Nov; 37(2):419-23. PubMed ID: 200714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of ocular murine cytomegalovirus infection.
    Hayashi K; Kurihara I; Uchida Y
    Invest Ophthalmol Vis Sci; 1985 Apr; 26(4):486-93. PubMed ID: 2984137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine cytomegalovirus ocular infection in immunocompetent and cyclophosphamide-treated mice. Potentiation of ocular infection by cyclophosphamide.
    Bale JF; O'Neil ME; Folberg R
    Invest Ophthalmol Vis Sci; 1991 May; 32(6):1749-56. PubMed ID: 1851731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Necrotizing retinopathy after intraocular inoculation of murine cytomegalovirus in immunosuppressed adult mice.
    Holland GN; Fang EN; Glasgow BJ; Zaragoza AM; Siegel LM; Graves MC; Saxton EH; Foos RY
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2326-34. PubMed ID: 2173685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus infection and disease in children: present state of knowledge.
    Diosi P
    Rev Roum Inframicrobiol; 1971; 8(4):217-21. PubMed ID: 4340443
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of T cells in mouse cytomegalovirus myocarditis.
    Lawson CM; O'Donoghue H; Reed WD
    Immunology; 1989 May; 67(1):132-4. PubMed ID: 2544512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple autoantibodies following cytomegalovirus infection: virus distribution and specificity of autoantibodies.
    Bartholomaeus WN; O'Donoghue H; Foti D; Lawson CM; Shellam GR; Reed WD
    Immunology; 1988 Jul; 64(3):397-405. PubMed ID: 2842252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of exogenous interferon on neonatal infection with murine cytomegalovirus.
    Cruz JM; Waner JL; Dammin GJ
    IARC Sci Publ (1971); 1978; (24 Pt 2):1067-71. PubMed ID: 221374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glomerulonephritis caused by murine cytomegalovirus. Potentiation by antithymocyte serum.
    Lussier G
    Vet Pathol; 1976; 13(2):123-30. PubMed ID: 180651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cytolytic T lymphocyte response to the murine cytomegalovirus. I. Distinct maturation stages of cytolytic T lymphocytes constitute the cellular immune response during acute infection of mice with the murine cytomegalovirus.
    Reddehase MJ; Keil GM; Koszinowski UH
    J Immunol; 1984 Jan; 132(1):482-9. PubMed ID: 6317749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inability of interferon to protect virus-infected cells against lysis by natural killer (NK) cells correlates with NK cell-mediated antiviral effects in vivo.
    Bukowski JF; Welsh RM
    J Immunol; 1985 Nov; 135(5):3537-41. PubMed ID: 2413125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disseminated cytomegalovirus disease in the guinea pig.
    Van Hoosier GL; Giddens WE; Gillett CS; Davis H
    Lab Anim Sci; 1985 Feb; 35(1):81-4. PubMed ID: 2984460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunology of cytomegalovirus: immunosuppressive effects during infections.
    Ho M
    Birth Defects Orig Artic Ser; 1984; 20(1):131-47. PubMed ID: 6203569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cells in cytomegalovirus infection: viral evasion and host countermeasures.
    Rölle A; Olweus J
    APMIS; 2009 May; 117(5-6):413-26. PubMed ID: 19400865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The oncogenic potential of human cytomegalovirus.
    Spector DH; Spector SA
    Prog Med Virol; 1984; 29():45-89. PubMed ID: 6322235
    [No Abstract]   [Full Text] [Related]  

  • 18. The murine cytomegalovirus as a model for the study of viral pathogenesis and persistent infections.
    Hudson JB
    Arch Virol; 1979; 62(1):1-29. PubMed ID: 231945
    [No Abstract]   [Full Text] [Related]  

  • 19. In vivo reactivation of latent murine cytomegalovirus in the eye by immunosuppressive treatment.
    Rabinovitch T; Oh JO; Minasi P
    Invest Ophthalmol Vis Sci; 1990 Apr; 31(4):657-63. PubMed ID: 2159448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replication of murine cytomegalovirus in murine Y-1 cells.
    Shanley JD; Lutwick LI; Donta ST
    J Med Virol; 1979; 4(4):261-8. PubMed ID: 232142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.